Incidence of Kidney Replacement Therapy and Subsequent Outcomes Among Patients With Systemic Lupus Erythematosus : Findings From the ERA Registry

↓ Direkt till sidans innehåll
↓ Direkt till sidans sekundära innehåll (sidomenyn)

Sökning: WFRF:(Pálsson Runólfur) > Incidence of Kidney...

Incidence of Kidney Replacement Therapy and Subsequent Outcomes Among Patients With Systemic Lupus Erythematosus : Findings From the ERA Registry

Derner, Ondrej (författare): General University Hospital in Prague

Kramer, Anneke (författare): Academic Medical Center of University of Amsterdam (AMC)

Hruskova, Zdenka (författare): General University Hospital in Prague

visa fler...

Arici, Mustafa (författare): Hacettepe University

Collart, Frederic (författare)

Finne, Patrik (författare): University of Helsinki

Fuentes Sánchez, Laura (författare): Hospital Regional de Málaga

Harambat, Jérôme (författare): Centre Hospitalier Universitaire de Bordeaux

Hemmelder, Marc H. (författare): Yukioka Hospital

Hommel, Kristine (författare): Holbæk Hospital

Kerschbaum, Julia (författare): Medical University of Innsbruck

De Meester, Johan (författare)

Palsson, Runolfur (författare): National University Hospital of Iceland

Segelmark, Mårten (författare): Lund University,Lunds universitet,Njurmedicin,Sektion II,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Nephrology,Section II,Department of Clinical Sciences, Lund,Faculty of Medicine,Skåne University Hospital

Skrunes, Rannveig (författare): Haukeland University Hospital,University of Bergen

Traynor, Jamie P. (författare): Scottish Renal Registry

Zurriaga, Oscar (författare): University of Valencia,CIBER Epidemiology and Public Health (CIBERESP)

Massy, Ziad A. (författare): CHU Ambroise Paré,Versailles Saint-Quentin-en-Yvelines University

Jager, Kitty J. (författare): Academic Medical Center of University of Amsterdam (AMC)

Stel, Vianda S. (författare): Academic Medical Center of University of Amsterdam (AMC)

Tesar, Vladimir (författare): General University Hospital in Prague

visa färre...

(creator_code:org_t)

Elsevier BV, 2022
2022
Engelska 11 s.
Ingår i: American Journal of Kidney Diseases. - : Elsevier BV. - 0272-6386. ; 79:5, s. 635-645

Relaterad länk:: http://dx.doi.org/10... (free); visa fler...; http://www.ajkd.org/...; https://lup.lub.lu.s...; https://doi.org/10.1...; visa färre...

Tidskriftsartikel (refereegranskat)

Abstract Ämnesord

Stäng

Rationale & Objective: There is a dearth of data characterizing patients receiving kidney replacement therapy (KRT) for kidney failure due to systemic lupus erythematosus (SLE) and their clinical outcomes. The aim of this study was to describe trends in incidence and prevalence of KRT among these patients as well as to compare their outcomes versus those of patients treated with KRT for diseases other than SLE. Study Design: Retrospective cohort study based on kidney registry data. Setting & Participants: Patients recorded in 14 registries of patients receiving KRT that provided data to the European Renal Association Registry between 1992 and 2016. Predictor: SLE as cause of kidney failure. Outcomes: Incidence and prevalence of KRT, patient survival while receiving KRT, patient and graft survival after kidney transplant, and specific causes of death. Analytical Approach: Kaplan-Meier methods and Cox regression models were fit to compare patient survival between the SLE and non-SLE groups, overall KRT, dialysis, and patient and graft survival after kidney transplant. Results: In total, 1,826 patients commenced KRT for kidney failure due to SLE, representing an incidence of 0.80 per million population (pmp) per year. The incidence remained stable during the study period (annual percent change, 0.1% [95% CI, −0.6% to 0.8%]). Patient survival among patients with SLE receiving KRT was similar to survival in the comparator group (hazard ratio [HR], 1.11 [95% CI, 0.99-1.23]). After kidney transplant, the risk of death was greater among patients with SLE than among patients in the comparator group (HR, 1.25 [95% CI, 1.02-1.53]), whereas the risk of all-cause graft failure was similar (HR, 1.09 [95% CI, 0.95-1.27]). Ten-year patient overall survival during KRT and patient and graft survival after kidney transplant improved over the study period (HRs of 0.71 [95% CI, 0.56-0.91], 0.43 [95% CI, 0.27-0.69], and 0.60 [95% CI, 0.43-0.84], respectively). Patients with SLE receiving KRT were significantly more likely to die of infections (24.8%) than patients in the comparator group (16.9%; P < 0.001). Limitations: No data were available on extrarenal manifestations of SLE, drug treatments, comorbidities, kidney transplant characteristics, or relapses of SLE. Conclusions: The prognosis of patients with SLE receiving KRT has improved over time. Survival of patients with SLE who required KRT was similar compared with patients who required KRT for other causes of kidney failure. Survival following kidney transplants was worse among patients with SLE.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Kardiologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cardiac and Cardiovascular Systems (hsv//eng)

Nyckelord

end-stage renal disease (ESRD)
Europe
incidence
kidney disease
kidney failure
kidney replacement therapy (KRT)
kidney transplantation
lupus nephritis (LN)
prevalence
prognosis
registry study
survival
Systemic lupus erythematosus (SLE)

Publikations- och innehållstyp

art (ämneskategori)
ref (ämneskategori)

Hitta via bibliotek

American Journal of Kidney Diseases (Sök värdpublikationen i LIBRIS)

Till lärosätets databas

Hitta mer i SwePub

Om ämnet

MEDICIN OCH HÄLSOVETENSKAP: MEDICIN OCH HÄLS ...; och Klinisk medicin; och Kardiologi

Artiklar i publikationen: American Journal ...

Av lärosätet: Lunds universitet

Sök utanför SwePub

Sök vidare i:: Google; Google Book Search; Google Scholar

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

LIBRIS.kb.se